Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations

Overview of attention for article published in Frontiers in immunology, June 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 8 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 34,466 followers.

Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations. #BtBsPub @UNIMIB #GranucciLab_BtBs #MarongiuLab_BtBs https://t.co/gGK

01 Aug 2022

Reply Repost Favourite

27 Jun 2022

Reply Repost Favourite

New Research: Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations: COVID-19 has proven to be particularly… https://t.co/j7

10 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.